Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Long-range function of secreted small nucleolar RNAs that direct 2'-O-methylation.

Rimer JM, Lee J, Holley CL, Crowder RJ, Chen DL, Hanson PI, Ory DS, Schaffer JE.

J Biol Chem. 2018 Aug 24;293(34):13284-13296. doi: 10.1074/jbc.RA118.003410. Epub 2018 Jul 6.

2.

ER and PI3K independently modulate endocrine resistance in ER-positive breast cancer.

Van Tine BA, Crowder RJ, Ellis MJ.

Cancer Discov. 2011 Sep;1(4):287-8. doi: 10.1158/2159-8290.CD-11-0192.

3.

Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors.

Ma CX, Crowder RJ, Ellis MJ.

Steroids. 2011 Jul;76(8):750-2. doi: 10.1016/j.steroids.2011.02.023. Epub 2011 Mar 21. Review.

PMID:
21420991
4.

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.

Sanchez CG, Ma CX, Crowder RJ, Guintoli T, Phommaly C, Gao F, Lin L, Ellis MJ.

Breast Cancer Res. 2011 Mar 1;13(2):R21. doi: 10.1186/bcr2833.

5.

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.

Dunbier AK, Anderson H, Ghazoui Z, Folkerd EJ, A'hern R, Crowder RJ, Hoog J, Smith IE, Osin P, Nerurkar A, Parker JS, Perou CM, Ellis MJ, Dowsett M.

J Clin Oncol. 2010 Mar 1;28(7):1161-7. doi: 10.1200/JCO.2009.23.9616. Epub 2010 Feb 1.

6.

PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.

Crowder RJ, Phommaly C, Tao Y, Hoog J, Luo J, Perou CM, Parker JS, Miller MA, Huntsman DG, Lin L, Snider J, Davies SR, Olson JA Jr, Watson MA, Saporita A, Weber JD, Ellis MJ.

Cancer Res. 2009 May 1;69(9):3955-62. doi: 10.1158/0008-5472.CAN-08-4450. Epub 2009 Apr 14.

7.

Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway.

Crowder RJ, Ellis MJ.

Breast Cancer Res. 2005;7(5):212-4. Epub 2005 Aug 5.

8.

Successful targeting of ErbB2 receptors-is PTEN the key?

Crowder RJ, Lombardi DP, Ellis MJ.

Cancer Cell. 2004 Aug;6(2):103-4.

9.

Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth.

Crowder RJ, Enomoto H, Yang M, Johnson EM Jr, Milbrandt J.

J Biol Chem. 2004 Oct 1;279(40):42072-81. Epub 2004 Jul 30.

10.

Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival.

Encinas M, Crowder RJ, Milbrandt J, Johnson EM Jr.

J Biol Chem. 2004 Apr 30;279(18):18262-9. Epub 2004 Feb 6.

11.

NGF deprivation-induced gene expression: after ten years, where do we stand?

Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA, Xie L.

Prog Brain Res. 2004;146:111-26. Review.

PMID:
14699960
12.

Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons.

Besirli CG, Deckwerth TL, Crowder RJ, Freeman RS, Johnson EM Jr.

Cell Death Differ. 2003 Sep;10(9):1045-58.

13.

The long and short isoforms of Ret function as independent signaling complexes.

Tsui-Pierchala BA, Ahrens RC, Crowder RJ, Milbrandt J, Johnson EM Jr.

J Biol Chem. 2002 Sep 13;277(37):34618-25. Epub 2002 Jun 28.

16.

Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons.

Lipscomb EA, Sarmiere PD, Crowder RJ, Freeman RS.

J Neurochem. 1999 Jul;73(1):429-32.

18.

Reaction of trifluoroacetaldehyde with amino acids, nucleotides, lipid nucleophiles, and their analogs.

Yin H, Crowder RJ, Jones JP, Anders MW.

Chem Res Toxicol. 1996 Jan-Feb;9(1):140-6.

PMID:
8924583
19.

Morphology of the male system and spermatophores of the arrowworm Ferosagitta hispida (Chaetognatha).

Bergey MA, Crowder RJ, Shinn GL.

J Morphol. 1994 Sep;221(3):321-341. doi: 10.1002/jmor.1052210307.

PMID:
29865409

Supplemental Content

Loading ...
Support Center